发明名称 Enhanced bimatoprost ophthalmic solution
摘要 A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.
申请公布号 US9155716(B2) 申请公布日期 2015.10.13
申请号 US201313826047 申请日期 2013.03.14
申请人 Allergan, Inc. 发明人 Chang Chin-Ming;Chang James N.;Schiffman Rhett M.;Jordan R. Scott;Chang-Lin Joan-En
分类号 A61K31/164;A61K9/00;A61K9/08;A61K31/14;A61K31/5575;A61K47/18;A61K31/165 主分类号 A61K31/164
代理机构 代理人 Siddiqi Lorenz
主权项 1. A method of lowering intraocular pressure in a person with glaucoma or ocular hypertension, the method comprising administering once daily to an eye of the person a first composition comprising about 0.01% w/v bimatoprost and about 0.02% w/v benzalkonium chloride, wherein the method lowers intraocular pressure as effectively and results in improved ocular surface tolerability as compared to the once daily administration of a second composition comprising 0.03% w/v bimatoprost and 0.005% w/v benzalkonium chloride.
地址 Irvine CA US